Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
p53 status in locally advanced bladder cancer.
Dizdar O, Demirci U.
J Clin Oncol. 2012 Jan 20;30(3):339; author reply 339-40. Epub 2011 Dec 19. No abstract available.
Related citations
Prostatic urethral recurrence of urachal adenocarcinoma.
Ching CB, Chen L, Fergany A.
J Clin Oncol. 2011 Oct 1;29(28):e736-8. Epub 2011 Sep 6. No abstract available.
Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 status.
Stadler WM, Lerner SP, Groshen S, Stein JP, Shi SR, Raghavan D, Esrig D, Steinberg G, Wood D, Klotz L, Hall C, Skinner DG, Cote RJ.
J Clin Oncol. 2011 Sep 1;29(25):3443-9. Epub 2011 Aug 1.
Nicotinic acetylcholine receptor polymorphism, smoking behavior, and tobacco-related cancer and lung and cardiovascular diseases: a cohort study.
Kaur-Knudsen D, Bojesen SE, Tybjærg-Hansen A, Nordestgaard BG.
J Clin Oncol. 2011 Jul 20;29(21):2875-82. Epub 2011 Jun 6.
Basaloid squamous cell carcinoma in the urinary bladder with small-cell carcinoma.
Neves TR, Soares MJ, Monteiro PG, Lima MS, Monteiro HG.
J Clin Oncol. 2011 May 20;29(15):e440-2. Epub 2011 Mar 14. No abstract available.
Phase II trial of cisplatin, gemcitabine, and bevacizumab as first-line therapy for metastatic urothelial carcinoma: Hoosier Oncology Group GU 04-75.
Hahn NM, Stadler WM, Zon RT, Waterhouse D, Picus J, Nattam S, Johnson CS, Perkins SM, Waddell MJ, Sweeney CJ; Hoosier Oncology Group.
J Clin Oncol. 2011 Apr 20;29(12):1525-30. Epub 2011 Mar 21.
International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial.
International Collaboration of Trialists; Medical Research Council Advanced Bladder Cancer Working Party (now the National Cancer Research Institute Bladder Cancer Clinical Studies Group); European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group; Australian Bladder Cancer Study Group; National Cancer Institute of Canada Clinical Trials Group; Finnbladder; Norwegian Bladder Cancer Study Group; Club Urologico Espanol de Tratamiento Oncologico Group, Griffiths G, Hall R, Sylvester R, Raghavan D, Parmar MK.
J Clin Oncol. 2011 Jun 1;29(16):2171-7. Epub 2011 Apr 18.
Kuhn's paradigms: are those closest to treating bladder cancer the last to appreciate the paradigm shift?
Bajorin DF, Herr HW.
J Clin Oncol. 2011 Jun 1;29(16):2135-7. Epub 2011 Apr 18. No abstract available.
Assessment of quality of cancer-related follow-up care from the cancer survivor's perspective.
Arora NK, Reeve BB, Hays RD, Clauser SB, Oakley-Girvan I.
J Clin Oncol. 2011 Apr 1;29(10):1280-9. Epub 2011 Feb 28.
DNA methylation array analysis identifies profiles of blood-derived DNA methylation associated with bladder cancer.
Marsit CJ, Koestler DC, Christensen BC, Karagas MR, Houseman EA, Kelsey KT.
J Clin Oncol. 2011 Mar 20;29(9):1133-9. Epub 2011 Feb 22.
Phase II study of conformal hypofractionated radiotherapy with concurrent gemcitabine in muscle-invasive bladder cancer.
Choudhury A, Swindell R, Logue JP, Elliott PA, Livsey JE, Wise M, Symonds P, Wylie JP, Ramani V, Sangar V, Lyons J, Bottomley I, McCaul D, Clarke NW, Kiltie AE, Cowan RA.
J Clin Oncol. 2011 Feb 20;29(6):733-8. Epub 2011 Jan 4.
Adenocarcinoma in an augmented bladder: result of a sequential dysplastic process.
Rosenberg S, Pizov G, Gofrit ON, Pode D.
J Clin Oncol. 2011 Jan 1;29(1):e1-2. Epub 2010 Sep 27. No abstract available.
Diagnostic pitfalls of rare urinary bladder tumors: differential diagnosis of lymphoma-like carcinoma of the bladder--a clinicopathologic study and literature review.
Wronski S, Marszalek A.
J Clin Oncol. 2011 Mar 10;29(8):e196-9. Epub 2010 Dec 28. Review. No abstract available.
Conjunctival melanoma: bladder and upper urinary tract metastases.
Nair BC, Williams NC, Cui C, Summers D, Mastrangelo MJ, Hubosky SG, Shields CL, Shields JA, Sato T.
J Clin Oncol. 2011 Mar 20;29(9):e216-9. Epub 2010 Dec 28. No abstract available.
Radiotherapy with concurrent carbogen and nicotinamide in bladder carcinoma.
Hoskin PJ, Rojas AM, Bentzen SM, Saunders MI.
J Clin Oncol. 2010 Nov 20;28(33):4912-8. Epub 2010 Oct 18.
Best supportive care compared with chemotherapy for unresectable gall bladder cancer: a randomized controlled study.
Sharma A, Dwary AD, Mohanti BK, Deo SV, Pal S, Sreenivas V, Raina V, Shukla NK, Thulkar S, Garg P, Chaudhary SP.
J Clin Oncol. 2010 Oct 20;28(30):4581-6. Epub 2010 Sep 20.
Clinical value of fluorine-18 2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in bladder cancer.
Apolo AB, Riches J, Schöder H, Akin O, Trout A, Milowsky MI, Bajorin DF.
J Clin Oncol. 2010 Sep 1;28(25):3973-8. Epub 2010 Aug 2.
Primary desmoplastic small round cell tumor of urinary bladder.
Li F, Li G, Chen Z, Bi C.
J Clin Oncol. 2010 Jun 20;28(18):e291-4. Epub 2010 May 10. No abstract available.
Expression signature of E2F1 and its associated genes predict superficial to invasive progression of bladder tumors.
Lee JS, Leem SH, Lee SY, Kim SC, Park ES, Kim SB, Kim SK, Kim YJ, Kim WJ, Chu IS.
J Clin Oncol. 2010 Jun 1;28(16):2660-7. Epub 2010 Apr 26.
Urologist density and county-level urologic cancer mortality.
Odisho AY, Cooperberg MR, Fradet V, Ahmad AE, Carroll PR.
J Clin Oncol. 2010 May 20;28(15):2499-504. Epub 2010 Apr 20.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on